Coramaze Technologies
Latest round
- Series A
Last raised
- Jun 2015
Total raised
- $6.5M
Investors
- 3
About Coramaze Technologies
Coramaze Technologies GmbH is a medical technology company focused on developing innovative solutions for tricuspid valve repair.Founded in 2013 and headquartered in Essen, Germany, Coramaze Technologies GmbH specializes in tricuspid valve repair solutions.Tripair™ is the flagship product of Coramaze, a pioneering tricuspid valve repair system designed to address the significant challenges posed by tricuspid regurgitation (TR). This investigational device aims to provide a simple, safe, and effective solution for TR, a heart valve condition that impacts millions globally and is often left untreated. Tripair™ functions by providing a minimally invasive alternative to traditional surgical interventions, making it a viable option for a broader patient population, including those who are typically ineligible for surgery. The device is intended to simplify the treatment process, making it accessible for interventionalists to perform with ease, akin to a right heart catheterization.The revenue model for Coramaze is centered around the commercialization of its investigational device, Tripair™, which is currently not available for purchase. The company is expected to engage in business-to-business (B2B) transactions with healthcare providers, hospitals, and clinics specializing in interventional cardiology, facilitating partnerships that enable these institutions to offer innovative TR treatment solutions to their patients. Revenue generation would typically occur upon the successful regulatory approval and subsequent market launch of Tripair™, where healthcare facilities would procure the device based on their patient needs and treatment protocols.S. markets by targeting hospitals and clinics specializing in interventional cardiology. The company is strategically positioned to advance these initiatives, aiming for market launch upon successful regulatory clearance.
Who invested in Coramaze Technologies
3 investors across 2 rounds
See all investors in Coramaze Technologies
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Coramaze Technologies
Who invested in Coramaze Technologies?
Coramaze Technologies has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Coramaze Technologies raised?
Coramaze Technologies has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Coramaze Technologies last raise money?
Coramaze Technologies's most recent round on record is a Series A, in Jun 2015.
What does Coramaze Technologies do?
Coramaze Technologies GmbH is a medical technology company focused on developing innovative solutions for tricuspid valve repair.
Where is Coramaze Technologies headquartered?
Coramaze Technologies is headquartered in Essen, Germany.
Which VCs invest in companies like Coramaze Technologies?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back medical devices & equipment companies at Coramaze Technologies's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series A
Raising like Coramaze Technologies? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.